US FDA Grants Breakthrough Therapy Designation to...
Category : ODD/BTA/FTA Status 14 November 2024US FDA grants breakthrough therapy designation to Johnson & Johnson’s nipocalimab to treat...
Odd Bta Fta Status
US FDA Grants Orphan Drug Designation to Leads Bio...
Category : ODD/BTA/FTA Status 8 November 2024US FDA grants orphan drug designation to Leads Biolabs’ LBL-034, a humanized bispecific T-cell...
Cumberland Pharmaceuticals Secures Orphan Drug and...
Category : ODD/BTA/FTA Status 8 November 2024Overview Cumberland Pharmaceuticals has announced that the US Food and Drug Administration (FDA)...
Denovo Biopharma Receives US FDA Fast Track Design...
Category : ODD/BTA/FTA Status 14 October 2024Denovo Biopharma receives US FDA fast track designation for its liafensine for treating patients wit...
FDA Grants Orphan Drug Designation to Can-Fite’s N...
Category : ODD/BTA/FTA Status 14 October 2024Overview Can-Fite BioPharma Ltd. a biotechnology company advancing a pipeline of proprietary smal...
Latest Newsletter Post
-
Foresee Pharma Gets Positive Recomm..
20 November 2024
-
EnteroBiotix Completes Patient Recr..
20 November 2024
-
Alnylam Reports Interim Phase 1 Dat..
20 November 2024
-
Foresee Pharma Gets Positive Recomm..
19 November 2024
-
European Union Recommends Approval..
19 November 2024
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com